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A B S T R A C T
Phosphotyrosine (pY) signaling is instrumental to numerous cellular processes. pY recognition occurs through
specialized protein modules, among which the Src-homology 2 (SH2) domain is the most common. SH2 domains
are small protein modules with an invariant fold, and are present in more than a hundred proteins with different
function. Here we ask the question of how such a structurally conserved, small protein domain can recognize
distinct phosphopeptides with the breath of binding affinity, specificity and kinetic parameters necessary for
proper control of pY-dependent signaling and rapid cellular response. We review the current knowledge on
structure, thermodynamics and kinetics of SH2–phosphopeptide complexes and conclude that selective phos-
phopeptide recognition is governed by both structure and dynamics of the SH2 domain, as well as by the kinetics
of the binding events. Further studies on the thermodynamic and kinetic properties of SH2–phosphopeptide
complexes, beyond their structure, are required to understand signaling regulation.
1. Introduction
Eukaryotic cells use phosphorylation of tyrosine residues as one of
the major routes of regulation of vital processes such as growth, sur-
vival, cytoskeletal reorganization, adhesion, metabolic homeostasis,
and others (Hunter, 2009). The abundance of the phosphotyrosine mark
(pY) is regulated by the opposing activities of protein tyrosine kinases
(PTKs), which catalyze the transfer of the γ-phosphate of ATP to the
hydroxyl group of tyrosine, and protein tyrosine phosphatases (PTPs),
which hydrolyze the phosphoester bond of phosphotyrosine. Next to
tyrosine, serine and threonine side chains can be phosphorylated to
yield phosphoserine (pSer) and phosphothreonine (pThr). Serine and
threonine phosphorylation accounts for more than 97% of phosphate
esterified to protein amino acids and is involved in several cellular
signaling pathways (Plattner and Bibb, 2012).
pY signaling requires the presence of protein domains capable of
binding specifically to amino acid sequences containing this residue.
Among them, Src-homology 2 (SH2) domains are by far the most
abundant and well characterized. Other notable examples of pY-re-
cognizing domains are the PTB (Kavanaugh et al., 1995), C2 (Benes
et al., 2005), HYB (Mukherjee et al., 2012) and pyruvate kinase M2
(Christofk et al., 2008) domains. In contrast, phosphorylation of serine
and threonine side chains acts predominantly to induce conformational
change, rather than mediating protein-protein interaction. Never-
theless, several modular domains (e.g. WW and FHA domains or 14-3-3
proteins) specifically recognize pSer and pThr marks (Yaffe and Elia,
2001).
In the context of pY signaling, the SH2 module was originally dis-
covered as a conserved subunit in the v-Fps/Fes tyrosine kinase
(Sadowski et al., 1986). SH2 domains consist of approximately 100
amino acids with an invariant fold, in which a central three-stranded
antiparallel β sheet, interspersed with shorter parallel β strands, is
flanked by two α helices. The secondary structure elements are joined
by loops, whose sequence and length are less conserved. Following the
convention introduced by Eck and coworkers in 1993, the strands are
named βA–βG, the helices are αA and αB, and the loops are named
according to the letters of the structural elements that they join.
Phosphopeptide residues are numbered based on their position relative
to pY (… pY-2, pY-1, pY+1, pY+2 …) (Eck et al., 1993) (Fig. 1A).
Approximately 120 different SH2 domains, distributed among more
than a hundred different proteins, have been identified in the human
genome (Liu et al., 2006), highlighting their importance in cell phy-
siology (Fig. 1B). In agreement, it has been proposed that the pY-sig-
naling machinery may have facilitated metazoan evolution (Shiu and
Li, 2004).
By specifically recognizing pY motifs, SH2 domains allow precise
https://doi.org/10.1016/j.yjsbx.2020.100026
Received 8 April 2020; Received in revised form 14 May 2020; Accepted 15 May 2020
⁎ Corresponding author at: Leibniz University Hannover, Institute of Organic Chemistry and Centre for Biomolecular Drug Research, Schneiderberg 38, 30167
Hannover, Germany.
E-mail address: teresa.carlomagno@oci.uni-hannover.de (T. Carlomagno).
Journal of Structural Biology: X 4 (2020) 100026
Available online 27 May 2020
2590-1524/ © 2020 Published by Elsevier Inc. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
T
spatial and temporal regulation of the proteins that contain the pY
mark. A prominent example is the protein adapter Grb2 in the context
of Ras/MAPK signaling, whose SH2 domain recognizes tyrosyl-phos-
phorylated sequences of the cytosolic domain of receptor tyrosine ki-
nases (RTKs): this allows the localization of the guanine-nucleotide
exchange factor SOS, which is bound to Grb2, in the proximity of Ras,
ultimately leading to its activation (Lemmon and Schlessinger, 2010).
Some SH2 domains regulate the activity of enzymes, such as Src-family
kinases Src, Yes, Fyn and Lyn (Boggon and Eck, 2004), tyrosine kinase
Abl (Hantschel et al., 2003), tyrosine phosphatases SHP1 and SHP2
(Hof et al., 1998), and phospholipase PLCγ1 (Bunney et al., 2012). In
addition, a subset of catalytically dead members in the PTP and dual-
specificity phosphatase (DSP) families recognize pY peptides through
other pY recognition domains, such as the PKCθ C2 or the pyruvate
kinase M2 (Hunter, 2009).
The functional importance of SH2 domains explains their involve-
ment in several human diseases. For example, mutations that abnor-
mally increase the affinity of the N-SH2 domain of SHP2 for pY-ligands
or disrupt its regulatory function have been implicated in the patho-
genesis of Noonan and LEOPARD syndromes (Tartaglia and Gelb,
2005), as well as several malignancies (Keilhack et al., 2005; Niihori
et al., 2005; Higashi et al., 2002). Furthermore, mutations in the
SH2D1A gene, which encodes for the SLAM-associated protein (SAP),
consisting almost exclusively of one SH2 domain, lead to the X-linked
lymphoproliferative syndrome (XLP) (Poy et al., 1999).
Precise spatial and temporal control of signaling cascades requires
fine-tuning of both the thermodynamic and kinetic parameters of the
binding events involved in the process. For example, high-affinity in-
teractions are long-lived and may provide higher specificity for one
selected target; however, they may also impair the ability to react to
rapidly changing conditions (Pawson, 2004). Specificity may be even
reduced by mutations that increase affinity, probably due to binding to
ectopic motifs (Kaneko et al., 2012; Kessels et al., 2002; Zarrinpar et al.,
2003). In agreement with this, the affinities of most SH2 domains for pY
motifs are modest.
The question of how a relatively invariant fold such as the SH2
domain achieves the specificity and binding kinetics required for proper
control of pY-dependent signaling has been the subject of intense in-
vestigation. Crystallographic structures and thermodynamic studies
have been extensively used to discover the specificity code. Over time,
the conventional view that SH2 domains achieve selectivity by making
specific interactions with peptide residues pY+1, pY+2 and pY+3 has
proven too simplistic. Nuclear magnetic resonance (NMR) studies of the
internal dynamics of SH2 domains have revealed new and unexpected
determinants of the specificity code. Furthermore, in vivo, where several
signaling pathways compete with each other, non-equilibrium pro-
cesses (i.e. the kinetics of binding) become relevant. In this review, we
discuss structural, dynamic, thermodynamic and kinetic data available
for SH2 domains in complex with pY motifs. The review is divided in
four sections summarizing structural (1), thermodynamic (2), dynamic
(3) and kinetic (4) data available on SH2–phosphopeptides complexes.
We conclude that a full understanding of binding specificity and reg-
ulation of enzyme activity through pY-dependent signaling requires
consideration of both structure and dynamics of the molecules in-
volved, as well as non-equilibrium kinetic processes.
2. Structure
A large number of high-resolution structures are available for
SH2–phosphopeptide complexes. The vast majority of SH2 domains
binds to phosphopeptides in a canonical, two-pronged way (Fig. 2A):
the peptide adopts an extended conformation, perpendicular to the
central β sheet, with the pY hosted in a groove lined by βB, βC, βD, αA
and the BC loop and held in place by electrostatic interactions and
hydrogen bonds to the phosphate group (Eck et al., 1993). A second
binding site, which is supposed to provide specificity to the interactions
with phosphopeptides, is built by a largely hydrophobic pocket de-
limited by CD, DE, EF, BG, βD and αB, and accommodates peptide
residues C-terminal to the pY. Despite substantial variations in the
amino acid sequence of its surrounding loops, the structure of this
pocket (termed the “specificity pocket”) is evolutionarily conserved
(Liu et al., 2011).
Fig. 1. General architecture of SH2 domains and their distribution in cellular proteins. (A) The crystal structure of the SH2 domain of Lck (PDB entry 1LCJ)
shows the highly conserved fold consisting of a central β-sheet core flanked by two α-helices. Minor variations in secondary structure elements have been reported in
other SH2 domains, including short β-strands before the first α-helix (βA) and after the BG loop (βG). The naming of secondary structure elements and loops follows
the convention of Eck et al. (1993). Secondary structure elements are color-coded (αA and αB in pink, βB in light green, βC and βD in orange, loops in grey) (B) Many
of the SH2 domain-containing proteins referred in this text feature a modular composition and exert a wide variety of roles in the cell. Proteins with SH2 domains
have also been implicated in chromatin remodeling, gene transcription, ubiquitination and cytoskeletal reorganization. For a more complete list, see Liu et al. (2006).
SH3: Src-homology 3; PH: Pleckstrin homology; PTP: Protein tyrosine phosphatase; PTK: Protein tyrosine kinase. (For interpretation of the references to color in this
figure legend, the reader is referred to the web version of this article.)
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The binding mode to the pY is similar in all SH2 domains (Waksman
et al., 1992) (Fig. 2B). A universally conserved arginine (ArgβB5),
whose side chain is buried from the solvent both in the free and pY-
bound forms, contributes a bidentate salt bridge to two oxygen atoms of
the phosphate group. Mutation of this residue abrogates pY binding
both in vitro (Bradshaw et al., 1999) and in vivo (Bibbins et al., 1993).
Other positively charged residues contribute to the stabilization of the
pY, although they are less critical and may not be present in all SH2
domains (ArgαA2 and LysβD6 in Src SH2). For example, ArgαA2 makes
a guanidino-aromatic interaction with the pY aromatic ring in Src-fa-
mily SH2 domains, but is absent in SHP2 N-SH2, where it is replaced by
a glycine (Lee et al., 1994; Huyer et al., 1995; Huyer and
Ramachandran, 1998). In Src SH2 both SerβB7 and ThrBC2 make hy-
drogen bonds with the pY phosphate, but their removal has only a
marginal effect on pY affinity (Bradshaw and Waksman, 2002)
(Fig. 2B). Interestingly, Src SH2 has a unique cysteine in the pY-binding
pocket (CysβC3): mutation of this residue to serine improves binding
affinity to phosphopeptides by 4- to 8-fold (Bradshaw et al., 1999). In
summary, binding of pY to SH2 domains is based on electrostatic in-
teractions, as confirmed by the dependence of the binding affinities on
pH (Bradshaw and Waksman, 1998; Singer and Forman-Kay, 1997) as
well as the nature and concentration of the buffer salt (Grucza et al.,
2000).
The binding mode to peptide residues other than pY is more variable
and has important consequences for the specificity of the different
classes of SH2 domains. Most SH2 domains, whose prototype is the Src
SH2 domain, bind phosphopeptides in the canonical or “two-pronged
plug” fashion (Fig. 2A): in addition to the pY-binding site, the “speci-
ficity pocket” buries the side chain of the pY+3 residue (Waksman
et al., 1993) (Fig. 2C). In Src SH2 the hydrophobic residues forming this
(+3) pocket are TyrβD5, LeuBG4, IleβE4, ThrEF1 and TyrαB9
(Fig. 2C). Residue βD5 has a crucial role in determining the specificity
for the pY+3 amino acid (Songyang et al., 1993; Huang et al., 2008).
Src SH2 and other Src-family kinase SH2 domains have an aromatic
residue at βD5, which dictates the requirement for a hydrophobic side
chain at pY+3, with Ile(+3), Leu(+3) and Val(+3) being the most
favored amino acids. The other protein–peptide interactions are gen-
erally less tight and/or mediated by water molecules (Bradshaw and
Waksman, 2002).
A few SH2 domains, which have an aliphatic residue at βD5 bind as
a two-pronged plug but require residues other than Ile, Leu or Val at pY
+3 (Huang et al., 2008)). For example, the SH2 domains of the p85
subunit of the phosphoinositide-3-kinase (PI3K) bind consensus se-
quences pY-M-X-M, where X is any amino acid: the presence of IleβD5
(p85 N-SH2) or CysβD5 (p85 C-SH2) instead of TyrβD5 (as in Src SH2)
makes the (+3) binding pocket narrower and deeper and at the same
time generates a second hydrophobic patch that accommodates a hy-
drophobic residue at pY+1 (Breeze et al., 1996; Nolte et al., 1996).
Besides the two-pronged plug model, several SH2 domains bind
peptide residues beyond pY in different ways. The C-SH2 domain of
PLCγ1, for example, has been shown to interact with phosphopeptide
residues up to pY+5/pY+6 by means of a mostly hydrophobic, ex-
tended, open groove (Pascal et al., 1994) (Fig. 2C). A similar extended
hydrophobic pocket is present in the SH2 domains of SHP2 and allows
the phenylalanine pY+5 of IRS1- or PD-1-derived peptides to bind
between the EF and BG loops (Lee et al., 1994; Marasco et al., 2020)
(Fig. 2C, D). SHP2 N-SH2 is rather unique in its versatility and binding
modes: in addition to its unusual requirement for a hydrophobic residue
at pY-2, dictated by the presence of a glycine at αA2, this domain is
capable of binding phosphopeptides by recognizing only residues N-
terminal to the pY (Qin et al., 2005), two phosphopeptides at the same
time (Zhang et al., 2011), or a phosphopeptide in a reverse direction
(Wang et al., 2018).
BRDG1 SH2 is another unusual SH2 domain, which has a defined
binding pocket for pY+4 and requires a leucine at this position. The
(+4) binding pocket resembles a pentagon basket and is structurally
conserved in all SH2 domains; however, except for BRDG1 SH2 and a
few other related SH2 domains, this pocket is inaccessible due to an
intramolecular interaction with a leucine or isoleucine of the BG loop
(Kaneko et al., 2010). The accessibility of the (+4) pocket is encoded in
the length and composition of the EF and BG loops: changing these two
features was demonstrated to alter the accessibility of the pocket and
thus the specificity of the SH2 domain (Kaneko et al., 2010; Liu et al.,
2019).
The Grb2 SH2 domain displays the most unconventional binding
mode to phosphopeptides (Fig. 2C). Despite having an aromatic residue
at βD5, it does not bind to the same consensus sequences as Src-family
kinase SH2 domains but has a very strong selectivity for peptides with
asparagine at pY+2. This feature is explained by the presence of a Trp
residue (TrpEF1) that occludes the (+3) binding pocket and forces the
peptide backbone to adopt a β-turn conformation (Rahuel et al., 1996).
In this unusual conformation, the amide group of the asparagine pro-
vides the hydrogen bonds necessary to stabilize the complex (Fig. 2E).
Finally, the SLAM-associated protein (SAP) lifts the paradigm that
pY is mandatory for the interaction. SAP consists almost exclusively of
an SH2 domain, which recognizes peptide sequences longer than usual
and makes specific interactions with peptide residues pY–3 and pY+2,
leading to a 3-pronged binding mode (Morra et al., 2001; Hwang et al.,
2002). Because of these additional contact points, SAP can bind non-
phosphorylated peptide sequences, although with lower affinity than in
the presence of pY. Likely, this peculiar binding mode is related to the
function of SAP: first, it can prevent phosphorylation of tyrosine-con-
taining sequences by binding to their non-phosphorylated state; second,
the tight, three-pronged binding to pY-containing peptides can shield
them from other SH2-docking sites or from phosphatase action (Poy
et al., 1999; Sayos et al., 1998; Peled et al., 2018).
In conclusion, despite the structural and sequence conservation of
SH2 domains, small differences in the amino acid sequence are able to
Fig. 2. Structural features of phosphopeptides recognition by SH2 domains. (A) Overview of the two-pronged plug binding mode as seen in the structure of the
Src SH2 domain in complex with the pYEEI peptide from the hamster polyomavirus middle-sized tumor antigen (PDB entry 1SPS). The color code is as in Fig. 1A (B)
The binding mode of the phosphotyrosine moiety is remarkably conserved among SH2 domains, as shown here by the Src (left, PDB entry 1SPS) and Lck (middle, PDB
entry 1LCJ) SH2 domains in complex with the pYEEI peptide from the hamster polyomavirus middle-sized tumor antigen, and the PLCγ1 C-SH2 domain in complex
with a phosphopeptide derived from PDGFR (right, PDB entry 2PLD). Specifically, a universally conserved arginine (ArgβB5) provides a bidentate hydrogen bond to
the phosphate group, corroborated by several amino acids from BC, αA, βC and βD, which show a greater degree of variability. (C) The “specificity pocket” of Src
SH2, lined by hydrophobic amino acids, is responsible for the recognition of phosphopeptide residue pY+3 (Ile in the pYEEI peptide), providing specificity to the
interaction (PDB entry 1SPS, two-pronged plug). Some SH2 domains recognize phosphopeptides in a different manner from the “two-pronged plug” binding mode
typical for SH2 domains of the Src-family kinases; for example, PLCγ1 C-SH2 recognizes phosphopeptide residues up to pY+5/pY+6 (PDB entry 2PLD), SHP2 N-SH2
engages in contacts with pY+5 (PDB entry 6ROY), while the presence of a bulky TrpEF1 in Grb2 SH2 forces the peptide to adopt a β-turn conformation (PDB entry
1TZE). Color coding according to the YRB method (Hagemans et al., 2015) (blue: nitrogens carrying positive charges, red: oxygens carrying negative charges, yellow:
hydrocarbon groups without polar substitutions.) (D) Zoom of the specificity pocket of Src SH2 in complex with the pYEEI peptide demonstrating the interaction
between the protein TyrβD5 and the peptide Ile(pY+3). (E) In addition to forcing the phosphopeptide to adopt a β-turn conformation, TrpEF1 of Grb2 imposes the
strict requirement of a glutamine at position pY+2 in phosphopeptides that bind this domain, since the side-chain amide group of this residue can make three
hydrogen bonds with LysβD6 and LeuβE4 (PDB entry 1TZE). In panels B-E, the color code is as in Fig. 1A with the exception that the loops in contact with the
phosphopeptide are in green. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)
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generate a wide diversity of binding modes that likely serves the pur-
pose of optimizing the thermodynamic parameters of the binding event
for its specific function and regulation.
3. Thermodynamics
The affinities of SH2 domains for cognate phosphopeptides span
around three orders of magnitude. A few examples of very high-affinity
SH2–phosphopeptide complexes have been reported in the literature,
such as the SHP2 N-SH2 domain in complex with a phosphopeptide
derived from IRS-1 (dissociation constant KD = 14 nM, (Sugimoto
et al., 1994)); however, most SH2 domains interact with phosphopep-
tides with a KD in the 100 nM – 10 µM range (Ladbury and Arold,
2011). The question of whether such moderate affinities serve a bio-
logical role has been recently addressed by Kaneko and coworkers
(Kaneko et al., 2012), who designed mutant constructs of the Fyn and
Src SH2 domains capable of binding pY ligands with substantially
higher affinities than the wild type proteins. Interestingly, when these
“pY superbinders” were expressed in HEK293 cells, they blocked EGFR
signaling and inhibited anchorage-independent cell proliferation, in-
dicating that tight binding of SH2 domains to pY ligands is detrimental
for function. It was proposed that moderate affinities serve the purpose
of maintaining the rapid dynamic control required in pY signaling
cascades (Pawson, 2004).
Early studies investigated the energetics of the binding of pY-ligands
to SH2 domains by isothermal titration calorimetry (ITC) and showed
that in most cases the binding is driven by a large favorable enthalpy
contribution (ΔH) and a smaller, but also favorable, entropic con-
tribution (TΔS) (e.g. ΔH = −7.7 kcal/mol, TΔS = 1.5 kcal/mol for Src
SH2 in complex with pYEEI (Bradshaw et al., 1999); ΔH=−7.94 kcal/
mol, TΔS = 1.18 kcal/mol for Grb2 SH2 in complex with Shc-pY317
(McNemar et al., 1997)). On average, binding of the pY moiety alone
contributes approximately half of the total free energy of binding
(Bradshaw et al., 1999). This allows very efficient and specific re-
cognition of phosphorylated targets and depletes almost completely the
binding to non-phosphorylated peptides; however, it also leaves little
room for generating specificity through interactions with peptide re-
sidues N- or C-terminal to the pY (Ladbury and Arold, 2011).
In contrast to phosphopeptides, whose binding is driven by en-
thalpy, the binding of isolated phosphotyrosine is entropically driven.
The pY binding pocket is engaged in a network of hydrogen bonds to
water molecules in the protein apo state; these water molecules are
competed out by the phosphotyrosine, which forms a new network of
hydrogen bonds with the SH2 residues. The release of bound water
accounts for the increase in entropy (Ladbury and Arold, 2011). In-
terestingly, binding of isolated pY can cause perturbation of NMR
chemical shifts of SH2 domains also in regions distant from the binding
pocket, as revealed by solution NMR for the N-SH2 domain of SHP2
(data not shown), suggesting coupling between the pY binding pocket
and other secondary structure elements. In general, binding of the pY
moiety provides most of the favorable entropic change, while the
binding of the other peptide residues is enthalpically favorable and
associated with a negative entropy change. One contribution to the
negative entropy change may be provided by structural water mole-
cules, which have been found to mediate protein–peptide interactions
in several high-resolution X-ray structures of SH2–phosphopeptide
complexes (e.g. Lck SH2–phosphopeptide, PDB entry 1LCJ (Eck et al.,
1993); Src SH2–phosphopeptide, PDB entry 1SHB (Waksman et al.,
1992); BRDG1 SH2–phosphopeptide, PDB entry 3MAZ (Kaneko et al.,
2010)) (Waksman et al., 1993) (Fig. 3).
In a pioneering study, Songyang and coworkers used a phospho-
peptide library and affinity purification to unravel the contribution of
residues C-terminal to the phosphotyrosine (pY+1, pY+2 and pY+3)
to the binding specificity of distinct SH2 domains (Songyang et al.,
1993). Beads loaded with a single SH2 domain were incubated with the
phosphopeptide library and bound peptide sequences were isolated and
quantified. The authors also proposed a classification system of SH2
domains based on the identity of the residue at position βD5, which
forms a platform for the peptide backbone and has a direct interaction
with pY+1: a moderate correlation was found between SH2 domain
families and preferred binding motifs. The classification of SH2 do-
mains was updated later, resulting in three major groups, each of which
was further divided into several subgroups, accounting for fine-tuning
of specificity (Huang et al., 2008). In addition, the same authors found
that some SH2 domains also discriminate for residues N-terminal to the
phosphotyrosine.
Although very informative, all these studies lack a proper evaluation
of the difference in binding affinity between interactions to “specific”
and “non-specific” motifs (Ladbury and Arold, 2011). For those do-
mains where thermodynamic parameters were measured, the results
are apparently in contradiction with the conventional view that re-
sidues pY+1 to pY+3 strongly discriminate between specific and non-
specific interactions. For example, the pYEEI motif, which was de-
termined to be the best binding sequence for the Src SH2 domain,
shows only up to two orders of magnitude better affinity when com-
pared to two unrelated phosphopeptides (Bradshaw and Waksman,
2002; Bradshaw et al., 1998). Furthermore, conservative mutations at
positions pY+1, pY+2 and pY+3 diminished affinity of only threefold,
while mutations to alanine were necessary to cause a reduction in
binding affinity of one to two orders of magnitude (Bradshaw and
Waksman, 1999). This is somewhat surprising, considering that all
three residues immediately after pY are involved in an extensive net-
work of interactions with the protein. The strongest decrease in affinity
was obtained when Glu(+1) was replaced with a glycine (50-fold)
(Bradshaw and Waksman, 1999), as well as upon mutation of the in-
teracting protein residue TyrβD5 (Bradshaw et al., 2000), indicating
that the Glu(+1)-Hβ–TyrβD5-aromatic contact is energetically im-
portant in complexes involving SH2 domains of the Src family
(Bradshaw and Waksman, 1999) (Fig. 2D). Interestingly, mutation of Ile
(+3) to alanine did not have a large impact, even though the isoleucine
side chain is deeply accommodated in the hydrophobic specificity
pocket (Fig. 2D). Similarly, mild effects on affinity were measured upon
mutation of Src SH2 residues that interact with the EEI motif (Bradshaw
et al., 2000).
The analysis of thermodynamic data of sequentially mutated pep-
tides did not show any significant coupling between peptide residues
(Ladbury and Arold, 2011). Similarly, double mutant cycle experiments
failed to find any coupling between the Src SH2 residues and the
phosphopeptide residues C-terminal to pY (Bradshaw and Waksman,
1999; Lubman and Waksman, 2002), with the significant exception of
the interaction between Glu(+1) and LysβD3. The LysβD3Ala mutation
reduced the binding affinity for pYEEI, albeit not as much as Tyrβ-
D5Ala. Nearly full binding affinity could be restored when Glu(+1) was
also mutated to alanine. To explain this, Lubman and Waksman showed
that the energetic coupling between LysβD3 and Glu(+1) is due to the
presence of AspβC8 and AspCD2, whose negative potential is neu-
tralized by LysβD3 and instead interferes with Glu(+1) binding in the
LysβD3Ala mutant (Fig. 4) (Lubman and Waksman, 2002). The authors
proposed that selectivity at pY+1 is not due to a single interaction, but
rather to the entire functional patch formed by LysβD3, AspβC8,
AspCD2 and ArgAB6; the perturbation of this patch can also influence
the binding of distant residues (pY-1 and pY-2) (Lubman and Waksman,
2002).
Similar results were found for SH2 domains in proteins outside the
Src family. The p85 N-SH2 domain, which was originally shown to be
selective for Met(+3) (Songyang et al., 1993), binds randomized pep-
tides only 60-fold weaker than the optimal motif pYMXM (Piccione
et al., 1993); a more prominent loss in affinity was measured only upon
mutation of either of the two methionines to glycine (Günther et al.,
1996). For the C-SH2 domain of PLCγ1, only residue pY+1 was found
to contribute a large binding energy, although this domain interacts
with peptide residues up to pY+6 (Pascal et al., 1996; Kay et al., 1998).
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Uniquely, the SH2 domain of Grb2 has a very strong preference for
asparagine at pY+2 (Songyang et al., 1993) and the Asn(+2)Ala mu-
tation causes a 1000-fold decrease in affinity (McNemar et al., 1997).
Several signaling proteins have two or more different SH2 domains
arranged in tandem, which leads to far greater specificity than in the
case of individual SH2 domains. This is due both to the multiplicative
effect of the intrinsic binding specificity of each SH2 domain and to the
orientation and spacing requirements imposed by the tandem ar-
rangement on the pY sites (Ottinger et al., 1998). Ottinger et al, who
used surface plasmon resonance (SPR) to study the interaction of the
tandem SH2 domains of SHP2, PI3K p85, ZAP70/Syk and PLCγ1 with
several doubly phosphorylated tyrosine activation motifs, revealed that
each tandem SH2 binds the specific cognate ligand with very high af-
finity (KD in the pM–nM range); furthermore, the specificity measured
in competition experiments was found to be much higher than for
isolated SH2 domains with values in the range 1000-fold –10,000-fold
(Ottinger et al., 1998).
All these data indicate that the specificity of the SH2 domains for
their cognate phosphopeptide sequence is mild and allows for crosstalk
between different signaling pathways. Most of the proteins involved in
signaling contain multiple SH2 domains, sometimes accompanied by
other domains recognizing other moieties than phosphotyrosine. Likely,
it is the combination of these recognition events that builds up speci-
ficity while allowing for a granular, stepwise regulation of cellular re-
sponse.
Another take-home message from the thermodynamic data is that
binding affinities cannot be described as a sum of point interactions
between the ligand and the receptor protein: often, to explain changes
in binding energy upon mutations, one needs to invoke a network of
interactions, where the perturbation of a node results in subtle struc-
tural rearrangements throughout the network. In addition, entropic
contributions to the binding affinities, in form of protein and peptide
dynamics, may play a role as well. These will be discussed in the fol-
lowing section.
4. Dynamics
Besides the enthalpic contributions and the entropy increase due to
the release of bound water, changes in the internal dynamics of the
binding partners may modulate protein–peptide affinities and
Fig. 3. Structural water molecules mediating protein–peptide interactions. High-resolution crystal structures of three different SH2 domains, in which the
structural waters located within 6 Å of the phosphopeptide are shown as red spheres. The binding pockets of most SH2 domains have been shown to be hydrated: the
binding of the water molecules should contribute a negative entropy term to the free energy of binding. PDB entries: 1LCJ (Lck SH2), 1SHB (Src SH2), 3MAZ (BRDG1
SH2). The color code is as in Fig. 1A with the exception that the loops in contact with the phosphopeptide are in green. (For interpretation of the references to color in
this figure legend, the reader is referred to the web version of this article.)
Fig. 4. Structural consequences of mutations
on the binding surface of the pY+1 amino
acid. Comparison of the crystal structures of
wild-type Src SH2 (left, PDB entry 1SPS) and
triple-mutant Src SH2 (right, LysβD3Ala-
AspCD2Ala-AspβC8Ala, PDB entry 1KC2) in
complex with the pYEEI phosphopeptids.
Rreplacement of LysβD3 with an alanine reduces
the affinity of the SH2 domain for the phos-
phopeptide because the negative charges of
AspβC8 and AspCD2 are no longer shielded.
Notably, the CD loop is disordered in the triple
mutant SH2 domain.
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specificity. NMR spectroscopy is the major technique capable of mea-
suring differences in the dynamics of the unbound and bound states in a
large range of time scales.
In a pioneering study, Farrow et al. characterized the backbone
dynamics of unbound and bound states of the PLCγ1 C-SH2 domain in
the ps–ns time scale (Farrow et al., 1994). They found that phospho-
peptide binding is not associated with a reduction of protein mobility at
the binding site, as it had been previously measured for other pro-
tein–ligand complexes (Akke et al., 1993; Nicholson et al., 1992). In
general, PLCγ1 C-SH2 showed little high-frequency motions in its un-
bound state; peptide binding was associated with increased order
parameters (i.e. greater rigidity) of only a few residues, such as ArgβB7
in the pY binding pocket, while several other residues became more
disordered instead (Farrow et al., 1994). Measurements of slower dy-
namics, corresponding to conformational exchange processes in the
μs–ms time scale (quantified through the parameter Rex), showed no
significant change upon peptide binding either (Farrow et al., 1994). A
follow-up study measured the dynamics of peptide-bound PLCγ1 C-SH2
arginine side chains in the pY binding pocket (Pascal et al., 1995). This
SH2 domain features an unusually high number of arginines, four in
total, that can potentially interact with the phosphate group, while the
pY binding pockets of other SH2 domains, such as Src SH2 and SHP2 N-
SH2, contain either two or one conserved arginines, respectively. Three
of the four arginines of PLCγ1 C-SH2 (ArgαA2, ArgβB5 and ArgβB7) are
inaccessible to solvent: they showed limited fast motions but con-
siderable line broadening due to μs–ms time scale dynamics. Con-
versely, the fourth arginine (ArgβD6) was found to have considerable
high-frequency motions.
A major contribution to understanding the change of protein dy-
namics upon peptide binding and its impact on binding activity and
selectivity was made by the Kay laboratory with a study on sidechain
methyl-group motions of PLCγ1 C-SH2 in the ps–ns time scale (Kay
et al., 1996). The pY binding pocket was found to become more rigid
upon peptide binding, while the hydrophobic sidechains of the speci-
ficity pocket remained mobile, indicating a relaxed side-chain packing
in this region. Later, Kay and coworkers used this dynamic behavior to
explain the apparent conflict between structural data, which indicate
that PLCγ1 C-SH2 engages in extensive contacts with the phospho-
peptide (Pascal et al., 1994), and binding studies that show little in-
fluence of peptide mutations on the binding affinities (Kay et al., 1998).
They proposed that the presence of large-amplitude motions in the
hydrophobic surface of the specificity pocket, together with the very
steep distance-dependence of the van der Waals energy, lead to weaker
interactions in this region and thus greater permissivity (Kay et al.,
1996). In contrast, the specificity pocket of the SHP2 N-SH2 domain
bound to an IRS1-derived phosphopeptide is less flexible and the
truncation of the phosphopeptide C-terminal residues leads to a more
dramatic decrease in affinity than in the case of PLCγ1 C-SH2 (Kay
et al., 1998). Thus, a correlation seems to exist between ps–ns dynamics
and binding affinity, which can explain different specificity properties
of two structurally very similar domains. In the case of PLCγ1 C-SH2,
the high-frequency motions of the hydrophobic residues in the speci-
ficity pocket may serve the purpose of reducing the affinity for the
phosphopeptide and maintain reasonably fast dissociation rates. This
may become necessary due to the presence of four arginines in the pY
binding pocket of PLCγ1 C-SH2, which provide a far stronger electro-
static interaction with the phosphotyrosine than the single arginine in
SHP2 N-SH2.
More recently, Finerty et al. studied the backbone and sidechain
dynamics of a phosphopeptide (DNDpYIIPLPDPK) derived from PDGFR
bound to PLCγ1 C-SH2 (Finerty et al., 2005). Amide 15N order para-
meters identify pY, Ile(+1) and Ile(+2) as the most rigid amino acids.
Contrarily, methyl groups order parameters are all low, except for the
Ile(+1) γ2, thus mirroring the high level of dynamics of the protein
sidechains. The authors conclude that the intermolecular interface C-
terminal of pY is characterized by a high level of sidechain
conformational exchange, which modulates the affinity between the
ligand and the protein (Finerty et al., 2005).
Notably, PLCγ1 C-SH2 exists in solution in equilibrium between
monomeric and dimeric species, even at relatively low protein con-
centrations (Farrow et al., 1994). The dimerization seems to be medi-
ated by the large hydrophobic specificity pocket, which becomes
shielded by peptide binding, thus recapitulating the shift of the equi-
librium towards the monomeric state upon complex formation. A ten-
dency to dimerize has been observed also for SH2 domains of other
proteins, including fyn (Pintar et al., 1996), hck (Zhang et al., 1998)
and SAP (Finerty et al., 2002), although in these cases peptide binding
does not lead to complete dissociation of the dimers.
In summary, protein internal dynamics may have considerable in-
fluence on the strength of intermolecular interactions, finely tuning the
balance between specificity and permittivity as well as the capability to
respond to signaling.
5. Kinetics
The binding of signaling peptides to their receptors depends not
only on thermodynamic parameters, but also on the kinetics of the in-
termolecular interactions. Kinetic parameters are particularly relevant
in the presence of competitive binding partners with variable local
concentrations, as usually found in the cellular environment. Thus, in-
vivo the association and dissociation constants of the molecular com-
plexes involved in the signaling processes (kon and koff) cannot be ne-
glected.
Early studies used surface plasmon resonance (SPR) to measure the
kinetic parameters of SH2 domains binding to phosphopeptides in
isolated systems (Felder et al., 1993; Panayotou et al., 1993). Both
studies found very high kon rates (between 3 × 107 to 40 × 107 M−1
s−1 for the SH2 domains of p85 binding PDGFR-derived phosphopep-
tides (Felder et al., 1993) and 3.34 × 106 M−1 s−1 for p85 N-SH2
binding a peptide representing the pY751 site of PDGFR (Panayotou
et al., 1993)). The dissociation constants ranged from 0.11 to 0.19 s−1.
Surprisingly, the calculated KD values were in the range 0.3–3 nM,
namely two orders of magnitude smaller than those derived by ITC in
other studies. This discrepancy suggested a problem in the experimental
setup, which was later found to lay in the dimerization of the GST tag
attached to the SH2 domains leading to artefactual avidity effects in the
SPR experiments (Ladbury et al., 1995).
NMR studies, performing line shape analysis of the p85 N-SH2 do-
main signals upon titration of a peptide representing the pY751 site of
PDGFR, delivered much lower values for the dissociation constant: the
binding event was found to consist of two steps, presumably a first
encounter step followed by a conformational change step, with koff of
100 and 10 s−1, respectively (Hensmann et al., 1994). Thus, even in
vitro, the kinetic parameters of binding of phosphopeptides to SH2
domains, remain controversial.
The in vivo kinetics of pY-dependent signaling events has been ad-
dressed in more recent publications. Oh et al used total internal re-
flection microscopy to show that the dwell time of Grb2 SH2 near the
plasma membrane in the context of EGFR signaling is one order of
magnitude longer than the koff rate measured with isolated Grb2 and
membrane-embedded EGFR using single-molecule fluorescence
(Morimatsu et al., 2007) (0.52 s−1 in vivo versus 8 s−1 in the isolated
system) (Oh et al., 2012). This discrepancy was shown to result from
repeated rebinding of the Grb2 SH2 to multiple phosphotyrosine motifs
in vivo, which is facilitated by receptor clustering. The phenomenon of
rebinding in the presence of receptor clustering may also explain why
deletion of a single high-affinity phosphotyrosine site on a receptor
tyrosine kinase has only moderate effects on signaling (Oh et al., 2012).
When measuring the dwell times of tandem SH2 domains in the pre-
sence of multivalent phosphopeptides, Oh et al found a more complex
behavior, which they explained invoking the existence of both mono-
valent and divalent binding events; in divalent binding events, the data
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indicated that the binding of the first SH2 domain of the tandem to the
first pY site occurs much more rapidly than the binding of the second
SH2 domain to the second pY site (Oh et al., 2012). This result is in
agreement with our recent work on the interaction between the tyr-
osine-phosphatase SHP2, which contains two SH2 domains in tandem,
and a divalent peptide containing both the ITIM and ITSM pY sites of
the receptor PD-1: our data demonstrated that the second binding event
is slowed down by a conformational change in the linker joining the
two SH2 domains, which is required to adopt a conformation compa-
tible with the binding of the second pY site (Marasco et al., 2020).
In general, to understand the mechanisms of the fine regulation of
signaling events by local concentration and receptor clustering, as well
as the interplay between multiple signaling pathways, more kinetic data
need to become available both in vitro and in vivo.
6. Conclusions
The complexity of phosphotyrosine-dependent signaling is im-
pressive, especially since most of the pY recognizing domains belong to
the family of SH2 domains with a well-conserved fold and pY re-
cognition mode. The versatility in the function, specificity and reg-
ulatory capabilities of the SH2–phosphopeptide complexes relies on
different mechanisms. First, while all SH2 domains recognize the pY
mark with high specificity, the nature and strength of the interactions
with the amino acids surrounding the pY are variable. For each com-
plex, these interactions are tuned to yield sufficient specificity without
compromising turn over. The tuning is achieved by a delicate equili-
brium of enthalpic and entropic contributions to the binding energy,
including internal motions of the SH2 domain sidechains. Second, the
kinetics of the SH2–phosphopeptide interactions are likely to play an
important role in the regulation of signaling events in vivo, where each
phosphopeptide competes with others for SH2 domain binding, and
local concentrations of individual molecules can vary over a wide
range. Unfortunately, the kinetics of SH2–phosphopeptide complexes
have been poorly studied both in vitro and in vivo. Third, nature uses
multivalent binding events, relying on tandem SH2 domains and amino
acid sequences containing multiple phosphorylation sites, to generate a
large arsenal of both thermodynamic and kinetic parameters that can be
tuned as needed to yield specific function and rapid response to chan-
ging environmental conditions. All in all, static structures of isolated
SH2 domains bound to their cognate peptides are generally unable to
explain function and regulation of the cellular processes in which they
are involved; instead, they are the starting point for an exciting dis-
covery tour in the world of thermodynamics and kinetics of multivalent
and competing binding events.
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